Nasopharyngeal carcinoma: Epstein-barr virus significance

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 785-790

  Kottaridis, Stavros D ^a,d   Panotopoulou, Evi ^a   Diamantis, Ioannis ^b   Goula, Irini ^a   Danilidis, John ^c   Fountzilas, George ^c  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b UNIVERSITY OF BASEL   (Switzerland)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d Papanikolaou Res Center of Oncology   (Greece)

Author keywords

Epstein Barr; In situ hybridization; Nasophyngeal carcinoma; PCR

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IN SITU HYBRIDIZATION; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; STATISTICAL ANALYSIS; TUMOR VOLUME;

ANTIBODIES, VIRAL; BASE SEQUENCE; CARCINOMA; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION;

EID: 3142622919     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. De-The: Ho JHC and Muir CS: Nasopharyngeal carcinoma. In: Evans AS (ed), Viral Infection of Humans. New York: Plenum, 1982 pp. 621-652.
2. Ho HC: Nasopharyngeal carcinoma. In: Klein G and Weinhouses (eds). Advances in cancer Research. Vol 15, New York: Academin Press, 1972 pp.57-92.
3. Giajwani BW, Devereaux JM and Beg JA: Familiar clustering of nasopharyngeal carcinoma. Cancer 46: 2325-2327, 1980.
4. Levine PH, Wallen WC, Ablashi DV, Granlund DJ and Connelly R: Comperative studies on immunity to EBV-associated antigens in NPC patients in north America, Tunisia. Fraance and Hong Kong. Int J Cancer 20: 332-338, 1977.
5. Krueger GRF, Kottaridis SD, Wokf H, Ablashi DV, Sesterhenn K and Bertram G: Histological types of nasopharyngeal carcinoma as compared to EBV serology. Anticancer Res 1: 187-194, 1981.
6. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dieneman D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrich R, Loheck H, Sam LK, Aranjo I, Rickinson AB and Stein H: Epstein-Barr virus and carcinomas: Undifferentiated carcinomas hut not squamouscell carcinomas of the nasopharynx are regularly associated with the virus. J of Pathology, 165: 17-24, 1991.
7. Kottaridis SD, Dafnou M, Besbeas S and Garas: Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma and other neoplastic conditions. J Natl Cancer Inst 59: 89-91, 1977.
8. Henle G, and Henle W: Epstein-Barr virus specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17: 1-7, 1976.
9. Kottaridis SD, Goula I, Vissarakis K, Agnanti N and Katsenis T: EBV-serology in NPC patients in Greece. Cancer Campaign. Vol. 5 (Grundmann, E. Grueger G and Ablashi DV eds). Fisher Verlag, Stuugart, 1981.
10. Zeng Y, Zhang LG and Li HY: Serological mass survey for early detection of nasopharyngeal carcinoma in wuzhon city China. Int J Cancer 29:139-141, 1982.
11. Weiss LM, Movahed LA, Warnke RA and Sklar J: Detection of Epstein-Barr viral genomes in ReedSternberg cells of Hodgkin's disease. New Engl J Med 320: 502-506, 1989.
12. Hamilton-Dutoit J, Pallesen G, Franzmann MB: AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ hybridization. An J Pathol 138: 149-163, 1991.
13. Hamilton-Dutoit SJ, Delecluse HJ, Raphael M, Lenoir G and Pallesen G: Detection of Epstein-Barr virus genomes in AIDS related lymphomas: Sensitivity and specificity of in situ hybridization compared with southern blotting. J Clin Pathol 44: 676-681, 1991.
14. Poiesz B, Ehrlich G, Papsidero L and Sninsky J: Detection of human vetroviruses. In: AIDS: etiology, diagnosis, treatment and prevention (ed.). VDe Vita, S Hellman and S Rosenberg), p.137-154. Lippincott, Philadelphia.
15. Mack DH and Snisky JJ: A sensitive method for the identification of uncharacterized viruses related to know virus groups. Hepadnavirus. Model system. Proc Natl Acad Sci USA 85: 6977-6981, 1988.
16. Fountzilas G, Danilidis J, Sridhar KS, Kalogera-Foutzila A, Zaramboukas T, Sombolos K, DestouniSalem E, Vritios A and Tourkantonis A: Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyrea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region. Cancer 66: 1453-1460, 1990.
17. Weiss LM and Movahed LA: in situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoprofilecations. Am J Pathol 134: 651-659, 1989.
18. Diamantis ID, McGandy CE, Pult I, Widmann JJ, Gudat F and Bianchi L: Detection hepatitis C virus in liver needle biopsies by polymerase chain reaction. J of Hepatology 12: 402-405, 1991.
19. Zong YS, Sham JS, Ng MH. Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirectmirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer 69: 3-7, 1992.
20. Woolson RF. Statistical methods for the analysis of biomedical data. New York: Willey, 1987, pp. 215-221.
21. Lawrence JB, Villnave CA, Singer R, Sensitive high-resolution chromatin and chromosome mapping in situ: Presence and oriantation of two closely integrated copies of EBV in a lymphoma line. Cell 52: 51-61, 1988.
22. Kottaridis SD, Goula I and Kiparissiadis P: Epstein-Barr virus is not associated with head and neck neoplasms othen than nasopharyngeal carcinoma. Neoplasma 29: 327-331, 1982.
23. Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY and Liu MY. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familiar tendency. Anticancer Res 10: 547-554, 1990.